Immunotherapy for MS: clinical aspects and trials
G. C. EbersS,
Corresponding Author
G. C. EbersS
Department of Clinical Neurological Sciences, Division of Neurology, University Hospital, London, Ontario, Canada
Department of Clinical Neurological Sciences, University Hospital, London, Ontario, Canada
Search for more papers by this author W. A. Sibley,
W. A. Sibley
Department of Clinical Neurological Sciences, Division of Neurology, University Hospital, London, Ontario, Canada
Search for more papers by this author D. W. Paty,
D. W. Paty
Department of Clinical Neurological Sciences, Division of Neurology, University Hospital, London, Ontario, Canada
Search for more papers by this author
G. C. EbersS,
Corresponding Author
G. C. EbersS
Department of Clinical Neurological Sciences, Division of Neurology, University Hospital, London, Ontario, Canada
Department of Clinical Neurological Sciences, University Hospital, London, Ontario, Canada
Search for more papers by this author W. A. Sibley,
W. A. Sibley
Department of Clinical Neurological Sciences, Division of Neurology, University Hospital, London, Ontario, Canada
Search for more papers by this author D. W. Paty,
D. W. Paty
Department of Clinical Neurological Sciences, Division of Neurology, University Hospital, London, Ontario, Canada
Search for more papers by this author
First published: April 1995
No abstract is available for this article.
